Items where Author is "Hill, Adam"
Up a level |
Article
Cserne Szappanos, Henrietta and Viola, Helena M. and Ito, Danica W. and Lim, Seakcheng and Mangala, Melissa and Holliday, Mira and Barratt Ross, Samantha and Semsarian, Christopher and Hill, Adam and Dixon, Rose E. and Hool, Livia C. (2023) Cytoskeletal disarray increases arrhythmogenic vulnerability during sympathetic stimulation in a model of hypertrophic cardiomyopathy. Scientific Reports, 13 (1). ISSN 2045-2322
Li, Zhihua and Mirams, Gary R. and Yoshinaga, Takashi and Ridder, Bradley J. and Han, Xiaomei and Chen, Janell E. and Stockbridge, Norman L. and Wisialowski, Todd A. and Damiano, Bruce and Severi, Stefano and Morissette, Pierre and Kowey, Peter R. and Holbrook, Mark and Smith, Godfrey and Rasmusson, Randall L. and Liu, Michael and Song, Zhen and Qu, Zhilin and Leishman, Derek J. and Steidl‐Nichols, Jill and Rodriguez, Blanca and Bueno‐Orovio, Alfonso and Zhou, Xin and Passini, Elisa and Edwards, Andrew G. and Morotti, Stefano and Ni, Haibo and Grandi, Eleonora and Clancy, Colleen E. and Vandenberg, Jamie and Hill, Adam and Nakamura, Mikiko and Singer, Thomas and Polonchuk, Liudmila and Greiter‐Wilke, Andrea and Wang, Ken and Nave, Stephane and Fullerton, Aaron and Sobie, Eric A. and Paci, Michelangelo and Musuamba Tshinanu, Flora and Strauss, David G. (2020) General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy. Clinical Pharmacology & Therapeutics, 107. pp.102-111. ISSN 0009-9236
Lee, William and Windley, Monique J and Perry, Matthew D and Vandenberg, Jamie I and Hill, Adam (2019) Protocol-dependent differences in IC50 values measured in hERG assays occur in a predictable way and can be used to quantify state preference of drug binding. Molecular Pharmacology, ePub. pp. mol.118.115220. ISSN 0026-895X (OA)